hDHODH-IN-8 is a potent inhibitor of human dihydroorotate dehydrogenase (hDHODH) with an IC50 of 16 nM; it exhibits strong antiproliferative activity and excellent aqueous solubility; it has potential for the research of cancer diseases, particularly lymphoma.